IMM — ImmuPharma Share News
0.000.00%
Financial, Business and Portfolio Develop't Update
Holding(s) in Company
Holding(s) in Company
Holding(s) in Company
Holding(s) in Company
Brief: Immupharma HY Diluted Loss Per Share 0.25 Pence
WRAP Retail Offer for up to £0.5m
Subscription to raise £1.35m; Sharing Agr, RPT
Interim results
Brief: ImmuPharma Announces Extension Of Warrants In Incanthera
Directorate Change
UK's ImmuPharma jumps as Lupuzor Phase 2/3 clinical trial set to start in H2
Lupuzor Update
IMM RNS Posting of RA and Notice of AGM 30 June 23
Brief: Immupharma Plc Announces Positive Guidance From FDA For IND Application Of P140 In CIDP
UK's ImmuPharma drops on annual loss, lower year-end cash
Brief: Immupharma PLC Reports FY Loss For Period Of £3.8M
Final Results
Holding(s) in Company